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Background: Alternative splicing is an essential mechanism for increasing transcriptome and proteome diversity in
eukaryotes. Particularly in multicellular eukaryotes, this mechanism is involved in the regulation of developmental
and physiological processes like growth, differentiation and signal transduction.
Results: Here we report the genome-wide analysis of alternative splicing in the multicellular green alga Volvox
carteri. The bioinformatic analysis of 132,038 expressed sequence tags (ESTs) identified 580 alternative splicing
events in a total of 426 genes. The predominant type of alternative splicing in Volvox is intron retention (46.5%)
followed by alternative 5′ (17.9%) and 3′ (21.9%) splice sites and exon skipping (9.5%). Our analysis shows that in
Volvox at least ~2.9% of the intron-containing genes are subject to alternative splicing. Considering the total
number of sequenced ESTs, the Volvox genome seems to provide more favorable conditions (e.g., regarding length
and GC content of introns) for the occurrence of alternative splicing than the genome of its close unicellular relative
Chlamydomonas. Moreover, many randomly chosen alternatively spliced genes of Volvox do not show alternative
splicing in Chlamydomonas. Since the Volvox genome contains about the same number of protein-coding genes
as the Chlamydomonas genome (~14,500 protein-coding genes), we assumed that alternative splicing may play
a key role in generation of genomic diversity, which is required to evolve from a simple one-cell ancestor to a
multicellular organism with differentiated cell types (Mol Biol Evol 31:1402-1413, 2014). To confirm the alternative
splicing events identified by bioinformatic analysis, several genes with different types of alternatively splicing have
been selected followed by experimental verification of the predicted splice variants by RT-PCR.
Conclusions: The results show that our approach for prediction of alternative splicing events in Volvox was accurate
and reliable. Moreover, quantitative real-time RT-PCR appears to be useful in Volvox for analyses of relationships
between the appearance of specific alternative splicing variants and different kinds of physiological, metabolic and
developmental processes as well as responses to environmental changes.
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Alternative splicing of precursor messenger RNA (pre-
mRNA) is an important post-transcriptional regulatory
mechanism that enhances the transcriptome plasticity
and proteome diversity. Alternative splicing produces
multiple transcripts from a single gene by varying the se-
lection of the include/exclude regions. The different spli-
cing products of a single gene produce different protein
isoforms with different functions and effects [1-10].* Correspondence: kianian@uni-bielefeld.de; armin.hallmann@gmx.de
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article, unless otherwise stated.Alternative splicing can also introduce premature stop
codons, which cause down-regulation of expression of
the corresponding gene by nonsense-mediated decay
(NMD) of mRNA [11].
The five basic types of alternative splicing are as fol-
lows: 1) exon skipping, if an exon is either included in
or excluded from the pre-mRNA; 2) intron retention,
when an intron is either retained or excised from the
pre-mRNA; 3) alternative 5′ splice sites and 4) alterna-
tive 3′ splices site allow the extension or shortening of a
particular exon, depending on the use of a proximal or
distal 5′ and 3′ splice site, respectively; 5) mutually ex-
clusive exons occur when two or more adjacent cassetteCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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at a time in the mRNA [2,5,12].
Alternative splicing events are not rare, but quite
common in eukaryotes. In human, ~95% of all intron-
containing genes are alternatively spliced, ~60% in
Drosophila melanogaster, ~25% in Caenorhabditis ele-
gans and ~61% in Arabidopsis thaliana (hereafter
Arabidopsis) [13-21]. The real percentages might even
be higher than reported, because they correlate with
the number of sequenced ESTs. An increased number
of sequenced ESTs frequently reveal additional alterna-
tive splicing events because more and more rare spli-
cing variants from genes with low expression become
sequenced. For Arabidopsis the reported percentage of
alternatively spliced genes increased dramatically within
a decade: it was 1.2% in 2003 [22], 11.6% in 2004 [23],
more than 30% in 2006 [24], 42% in 2010 [18] and 61%
in 2012 [19].
In Arabidopsis, the most frequent alternative splicing
variant is intron retention (~40%) [18,19]. Most alterna-
tive splicing events in Arabidopsis, i.e. 78.4%, occur in
the coding region and about 50% of which produce a
premature termination codon that is a potential target
for NMD [5,25]. In addition, 15.2% of all alternative spli-
cing events occur in the 5′-untranslated region (UTR)
and 6.4% in the 3′ UTR [5]. In humans, the allocation
is quite different from Arabidopsis: the most common
alternative splicing variant is exon skipping (42-58%),
whereas intron retention forms only a small fraction
(5-9%) of all alternative splicing events [5,26].
Two main factors that affect the occurrence of alter-
native splicing are intron lengths and the nucleotide
composition of the introns [27]. Intronic nucleotide
composition has been shown to affect splicing effi-
ciency of intron retention [10,28-30]. Compared to the
average length of human introns, which is 3365 bp,
Arabidopsis introns are much shorter and show an
average length of only 170 bp [31,32]. In human introns
the AT content is only 51.9% [32], while plant introns
show a high AT content: in Arabidopsis it is 67% and in
rice it is 73% [5,33,34]. Moreover, the nucleotide com-
position of plant introns is also different between dicots
and monocots. In rice, for example, the introns are lon-
ger and have a higher GC content than in Arabidopsis,
which might be an indication for a different impact of
alternative splicing in these organisms [27,35-37].
Alternative splicing produces protein isoforms that dif-
fer from each other with regard to localization, enzym-
atic activity, signaling effects and protein stability [2-5].
In plants, alternative splicing was shown to be involved
in signal transduction and timing of flowering [5]. Alter-
native splicing can also act as a gene regulatory mechan-
ism during developmental processes or in response to
environmental conditions [2-6,8,9]. Various biotic andabiotic stress factors are known to influence alternative
splicing [4,6,38-41]. Relevant abiotic stress factors are
heavy metals, cold and heat. For example, the splicing of
polyubiquitin and hsp70 mRNAs in maize is affected by
a heat shock [42,43]. Biotic stress factors that influence
alternative splicing are viral and bacterial pathogens
[5,44,45]. Plants even seem to regulate their transcrip-
tome post-transcriptionally in response to quickly chan-
ging environmental conditions and pathogen attacks by
using alternative splicing mechanisms [39,46,47].
Like in higher plants and animals, alternative splicing
also is a common mechanism for increasing transcrip-
tome diversity in much simpler organisms like algae.
Previous studies in volvocine green algae, which include
unicellular forms like Chlamydomonas reinhardtii (here-
after Chlamydomonas) to colonial and multicellular forms
with increasing complexity like Volvox carteri (hereafter
Volvox), revealed a number of genes that undergo alterna-
tive splicing. Examples include algal-CAM [48] and
RBR1/mat3 [49,50] in Volvox and Cop1 [51] and CGE1
[52] in Chlamydomonas. A recent study about alternative
splicing in Chlamydomonas indicates that about 3% of all
genes in Chlamydomonas undergo alternative splicing
[53], which is much lower than recent reports from higher
plants (e.g., 61% in Arabidopsis; based on the analysis of
116 million paired-end RNA-seq reads of a normalized
cDNA library) [18,19]. The analysis of a large EST dataset
of Chlamydomonas resulted in 498 EST clusters that
show 611 alternative splicing events [53]. The results in-
dicated that 11.6% of the alternative splicing events in
Chlamydomonas (based on the analysis of 252,484
ESTs) are alternative 5′ splice sites, 25.8% are alterna-
tive 3′ splice sites, 0.7% show both alternative 5′ and 3′
splice sites and 11.9% show exon skipping. Like in Ara-
bidopsis, the most frequent alternative splicing event in
Chlamydomonas is intron retention, which accounts for
50% of all events [53].
Based on molecular-phylogenetic studies, Volvox and
Chlamydomonas probably diverged ∼ 200 million years
ago from a common unicellular ancestor [54]. On the
time-scales of evolution, the transition from unicellular
to multicellular life in Volvox is thus a quite recent occur-
rence when compared to other shifts to multicellularity.
Other transitions to multicellularity, such as the ones that
gave rise to plants and animals, occurred deep in the past,
approaching a billion years ago [55,56]. The evolution of
multicellular live in volvocine algae required several devel-
opmental traits including asymmetric cell division and
embryonic morphogenesis. Most probably, the first multi-
cellular volvocine algae were just small colonial organisms
(like Gonium) without differentiated cells. Later size, cell
number and overall complexity increased and a tendency
to cell differentiation evolved (like in Eudorina and Pleo-
dorina). Finally, even a complete division of labor between
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[57]. Comparative analyses of the Volvox and Chlamy-
domonas genomes revealed that the overall sequence
divergence between these organisms is comparable to
that between human and chicken (which diverged ~310
million years ago) and Arabidopsis and poplar (which
diverged ~110 million years ago). Moreover, despite
conserved synteny between the genomes, Volvox and
Chlamyomdonas show higher rates of genomic re-
arrangement than vertebrates and eudicots do [58]. The
nuclear genome of Chlamydomonas is 118 Mbp in size
and that of its multicellular relative Volvox is composed
of 138 Mbp. The larger genome of Volvox (~17% larger)
is attributed to its higher content of transposons and
repetitive DNA [58,59] because both species have al-
most identical protein-coding potentials, i.e., 14,516
and 14,520 protein-coding genes in Chlamydomonas
and Volvox, respectively. Only a few gene families, i.e.,
the pherophorin genes, the VMP genes (Volvox matrix
metalloproteases) and the cyclin-D related genes have
more members in Volvox than in Chlamydomonas [58].
This suggests that the transition from a unicellular,
Chlamydomonas-like ancestor to multicellular Volvox
did not take major changes in gene content [58,60] but
mainly alterations in the mechanisms of genetic regula-
tion. Thus, development of organismal complexity might
be mainly caused by evolutionary innovations of pre-
existing proteins (e.g., transcription factors) and their
binding sites, inventions of noncoding RNAs, innovations
in the mechanism of alternative splicing and increase of
alternative splicing events [58,61-64]. Alternative splicing
can produce different protein isoforms from a single gene,
which has produced only a single protein in an ancestor;
in this way, diversity increases. Together with differences
in selection pressures within a population, appearance or
changes in alternative splicing can lead to speciation.
Interestingly, two key factors that affect the splicing
mechanism are different between the genomes of Chlamy-
domonas and Volvox: the intron length and the nucleotide
composition. With an average length of 491 bp, the in-
trons of Volvox are clearly larger than Chlamydomonas in-
trons, which span only 371 bp on average [58] (Additional
file 1: Table S1). Bioinformatic analyses showed that exons
flanked by longer introns are more frequently subject to
alternative splicing events than exons flanked by short
introns [65,66]. Furthermore, the genome of Volvox shows
a lower GC content (56%) than the genome of Chlamydo-
monas (64%) [58,59], which might cause differences be-
tween the two species in alternative splicing [27,35]. Based
on these two key differences between both genomes, a de-
tailed investigation of alternative splicing may reveal new
insights into the gene regulation mechanisms that have
been required for the evolutionary transition from unicel-
lular Chlamydomonas to multicellular Volvox, while thenumber of genes remained about the same during this
transition.
Here we report the analysis of alternative splicing in the
multicellular green alga Volvox. After bioinformatic ana-
lysis of 132,038 ESTs, we identified 580 alternative splicing
events corresponding to 426 genes. We show the distribu-
tion of the different types of alternative splicing events in
Volvox and compare it with other species. To confirm our
bioinformatic results, several alternatively spliced genes
have been selected as representatives for experimental
verification. After confirmation of alternative splicing vari-
ants by reverse transcription polymerase chain reaction
(RT-PCR), the relative expression level of each splice vari-
ant was determined using quantitative real-time RT-PCR.
Our results indicate that alternative splicing is a wide-
spread process for generating protein isoform diversity
in Volvox, which suggests an important role of alterna-
tive splicing for expansion of organismal complexity dur-
ing evolution of multicellularity and cell differentiation
in volvocine algae.
Results
Genomic mapping of ESTs
The genome-wide analysis of alternative splicing in Volvox
and its comparison with both a closely related unicellular
alga (Chlamydomonas) and a more distantly related higher
plant (Arabidopsis) required both extensive genomic and
EST sequence data. These data were obtained from the
corresponding databases of Volvox [58], Chlamydomonas
[59] and Arabidopsis [31] (see Methods). The data sets of
the three species were treated in the same way to provide
the necessary comparability.
All available ESTs of the three species were aligned to
the corresponding genomic contigs and genome se-
quences using BLAT, a BLAST-like alignment tool [67].
Only the best alignment was used to avoid double
counting of paralogs. EST sequences with less than 95%
identity to any sequence in the corresponding genome
were removed from further analysis. The resulting align-
ments were then clustered by their genomic location. In
this process a cluster arises from the set of all ESTs,
which overlap at a given genomic location.
Subsequently, the splice site consensus sequences were
identified for all splicing events. The vast majority of in-
trons in protein-coding genes of Volvox and of any other
previously investigated eukaryote are canonical, which
means that they have a GT dinucleotide at their 5′ end
and an AG dinucleotide their 3′ end [68]. Only about 1-
2% of the introns are non-canonical. To compensate for
artefacts that may occur in further analysis, we omitted al-
ternative splicing events that involved introns with non-
canonical splice site dinucleotides (i.e., not GT/AG).
Then, alternative splicing graphs of potential splice
variants were constructed for each cluster in the three
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graph when there was EST evidence of a transcript with
canonical splice sites.
A representative sample of one alternative splicing
locus out of 6,925 loci in Volvox is shown in Figure 1. At
the 6,925 loci we identified 31,885 exons. This gives an
average of 4.6 exons per locus.
Alternative splicing analysis and abundance of splicing
events
After genomic mapping of all available ESTs, we identi-
fied the alternatively spliced isoforms for each locus in
Volvox, Chlamydomonas and Arabidopsis. Isoforms with
alternative transcription starts or ends were not consid-
ered further in this paper, because we focus here on alter-
native splicing events. The alternatively spliced isoforms
were divided into four major groups of events: exon skip-
ping, intron retention, alternative 5′ and alternative 3′Figure 1 Representative sample of one alternative splicing locus out of
serine threonine phosphatase. (A) Number of the corresponding genomic scaf
all splicing events at the given locus; the lengths of introns and exons are indic
two variants). The longest open reading frame is shown in blue color; the leng
all ESTs that were mapped to this genomic locus. The names of the ESTs (left s
nlm.nih.gov/dbEST/).splicing. In addition, there were instances of more com-
plex splice forms, which were not covered by the above
four simple alternative splicing events. To obtain splicing
events with a high quality, we complement our predictions
by a quality value to penalize the spurious events with
poor EST support.
The bioinformatic analysis identified 580 alternative
splicing events in Volvox in a total of 426 genes. Thus,
about 2.9% of all ~14,500 protein-coding Volvox genes
are subject to alternative splicing. This percentage is
more similar to the one observed in higher plants than
to that in the closely related unicellular relative Chlamy-
domonas; considering the number of analyzed ESTs.
The analysis of the different types of alternative spli-
cing revealed that 9.5% of all alternative splicing events
show exon skipping in Volvox, 46.5% show intron reten-
tion, 17.9% alternative 5′ splice sites and 21.9% alterna-
tive 3′ splice sites (Figure 2A). Thus, the predominant6925 loci in Volvox. The generated graph shows locus 3667, a gene for a
fold. (B) Nucleotide position within scaffold. (C) Cumulated graph with
ated. (D) Separate depiction of all identified splicing variants (here
th of the open reading frame is shown on the left side. (E) Depiction of
ide) are just as deposited in the GenBank EST database (http://www.ncbi.
Figure 2 Distribution of the different types of alternative splicing events. The percentage and total number (in parenthesis) of splicing events is
shown for each type of alternative splicing, i.e., intron retention (IR), exon skipping (ES), alternative 5′ splice site (Alt5′) and alternative 3′ splice site
(Alt3′). Asterisks (*) indicate the percentage of other, more complex alternative splicing types. The distribution is given for the species Volvox (A),
Chlamydomonas (B), Arabidopsis (C) and human (D). The total number of alternative splicing events is 580 in Volvox, 493 in Chlamydomonas and 9,343
in Arabidopsis.
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followed by alternative 3′ splice sites, alternative 5′
splice sites and exon skipping.
In the closely related alga Chlamydomonas, the intron
retention also is the most common type of alternative spli-
cing (46%), followed by alternative 3′ splice sites (25.6%),
alternative 5′ splice sites (13.4%) and exon skipping
(11.2%) (Figure 2B). In Arabidopsis, the prevalence of dif-
ferent alternative splicing types shows the same distribu-
tion as in Volvox and Chlamydomonas, i.e. the percentage
decreases in the following order: intron retention > alter-
native 3′ splice sites > alternative 5′ splice sites > exon
skipping (Figure 2C). In contrast to non-plant model or-
ganisms like human (Figure 2D), exon skipping is the
rarest simple form of alternative splicing in all of the three
investigated species (Figures 2A-C).
Localization of alternative splicing events
In Volvox, the majority of all alternative splicing events
(66.7%) affect the coding regions. Another 33.3% occur
within non-coding regions (14.8% in 5′ UTRs and 18.5%
in 3′ UTRs) (Figure 3A). The results from Volvox were
again compared with the genome and EST data of
Chlamydomonas and Arabidopsis [31,59], which were
treated in the same way as the data from Volvox (seeFigure 3 Localization of alternative splicing events in the mRNAs. In t
mRNA was divided into coding region, 5′ UTR or 3′ UTR. The percentage a
these mRNA regions. The splicing events totaled together 426 events in VoMethods). In Chlamydomonas, 10.8% of the alternative
splicing events were detected in 5′ UTRs and 10.1% in
3′ UTRs (Figure 3B). In Arabidopsis, 12.8% of the alter-
native splicing events were localized in 5′ UTRs and
15.7% in 3′ UTRs (Figure 3C). In both organisms, the
majority of alternative splicing events occur within the
coding region, just as observed in Volvox. More pre-
cisely, it was 79.1% in Chlamydomonas and 71.5% in
Arabidopsis (Figures 3B and 3C).
Experimental verification of alternative splicing events
To validate the quality of both the used ESTs and our
bioinformatic analysis, ten sample genes with identified
alternative splicing events were selected for experimental
verification by RT-PCR and quantitative real time RT-
PCR (Additional file 1: Table S2). The decisive factor in
the choice of a sample gene to be tested was the poten-
tial modification of protein domains or protein sequence
motifs by alternative splicing. Strong EST support, how-
ever, was not relevant for our selection. As a consequence
of this approach, for some of the selected sample genes,
like the genes for the mitochondrial translation elongation
factor Tu (efg8) and the selenocysteine-specific elongation
factor (selEFf) [50], only one supporting EST for a given
alternative splicing variant was available. By contrast, forhe species Volvox (A), Chlamydomonas (B) and Arabidopsis (C) each
nd total number (in parenthesis) of splicing events is given for each of
lvox, 535 in Chlamydomonas and 8,742 in Arabidopsis.
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cer protein 1 (ooe1), more than one hundred ESTs existed
(data not shown).
The statistical evaluation of the data obtained from our
bioinformatic analysis of alternative splicing indicates that
splice variants of genes that show exon skipping lead more
frequently to changes in protein properties (like protein
localization and activity) than genes showing any other
type of alternative splicing (data not shown). For that
reason, the following seven sample genes with exon
skipping and (putative) differences in the properties of
the protein variants were selected: clpr2 (chloroplast
Clp protease), efg8 (mitochondrial translation elong-
ation factor Tu), hyd2 (iron hydrogenase), lsg2 (matrix
metalloproteinase), mgmt (6-O-methylguanine DNA
methyltransferase), nrnp1 (nuclear ribonucleoprotein)
and selEFf (selenocysteine-specific elongation factor)
(Figure 4 and Additional file 1: Table S2). Of particular
interest was the experimental verification of the spli-
cing products of efg8 and selEFf because of their un-
common gene structures with extremely long introns,
which were 10772 bp (efg8) and 16365 bp (selEFf ) in
length (Figure 4).
In addition to exon skipping, we chose three further
sample genes with other types of alternative splicing,
which also lead to changes in protein properties. The se-
lected genes were cyn23 (cyclophilin-type peptidyl-prolyl
cis-trans isomerase), which shows alternative splicing via
mutually exclusive exons, oee1 (oxygen evolving enhan-
cer protein 1), which is an example for intron retention,
and ppi1 (protein phosphatase inhibitor), which pro-
duces protein isoforms through alternative 5′ splice sites
(Figure 4 and Additional file 1: Table S2).
To allow for a distinction of the different splice vari-
ants of a given gene, we named the variants “first” and
“second” splice variant. More precisely, the variant that
shows an exon-intron structure identical or similar to a
gene structure predicted as part of the Volvox genome
project [58] or in a database entry (Additional file 1:
Table S2) was called “first splice variant” and another
splice variant was called “second splice variant”.
Verification of exon skipping
The first of the seven sample genes with exon skipping
was clpr2. This gene codes for a highly conserved, ATP-
dependent serine protease [69], which shows 86% iden-
tity to Chlamydomonas CLPR2 in an overlap of 285
amino acid residues [70]. Clp proteases are involved in
many cellular and extracellular processes such as deg-
radation of misfolded proteins, cell signaling and remov-
ing of short-lived regulatory proteins [69,71]. The clpr2
gene of Volvox is 2,599 bp in length (from start to stop
codon) and includes 8 exons and 7 introns (Figure 4A,
Additional file 1: Table S2). In the second splice variantof clpr2, exon five that is 135 bp in length is excluded
from the mRNA by exon skipping (Figure 4A). The first
splice variant encodes a 284-residue polypeptide whereas
the second splicing variant encodes a 239-residue poly-
peptide (Additional file 1: Figure S1A, Additional file 1:
Table S2). The structure of the ClpP protein isoform
encoded by the second splice variant probably differs
from the reported protein structure of ClpP [72], which
is encoded by the first splice variant (Additional file 1:
Figure S1B). The conserved amino acid residues F100,
N111, Y119 and L120, which are involved in the α/β-
type fold of the protein [72], are lacking in the second
protein variant of clpr2 (Additional file 1: Figure S1A).
Both splice variants of clpr2 have been amplified by RT-
PCR to confirm the results of the bioinformatic analysis.
For it, total RNA was isolated from synchronously grow-
ing female Volvox cultures at the stage of hatching. Pairs
of primers were established to amplify each splice vari-
ant separately. For amplification of the first splice variant
of clpr2, one primer, ON15266, resides on exon 5, which
is lacking in the mRNA of the second splice variant; the
second primer is ON15265 on exon 4 (Figure 4A and
Additional file 1: Table S3). For verification of the sec-
ond splice variant, one primer, ON15267, only binds to
the exon-exon junction of exons 4 and 6, which emerges
only after removal of a 659 bp fragment between exon 4
and exon 6 by splicing; the second primer was ON15265
on exon 4 (Figure 4A and Additional file 1: Table S3). A
134-bp cDNA fragment was predicted for variant 1 and
a 117-bp fragment for variant 2; the RT-PCR yielded
fragments of the expected sizes (Figure 5A, Additional
file 1: Table S3). It was also possible to amplify both vari-
ants in one and the same reaction using only a single
pair of primers (ON15265 and ON15371, Figure 4A and
in Additional file 1: Table S3). Fragments of 278 bp (vari-
ant 1) and 143 bp (variant 2) were expected and actually
obtained in the RT-PCR (Figure 6 and Additional file 1:
Table S3); it should be mentioned that in addition to the
correct fragments, some non-specific side products were
amplified (Figure 6). Subsequently, the relative expression
levels of both splice variants were measured by quantitative
real-time RT-PCR, which is a sensitive method for analyz-
ing relative expression levels of alternative splicing variants
[49,73-75]. As a reference gene for the quantitative real-
time RT-PCRs the actin gene was used. The actin gene
already has been used in previous studies as a reference in
RT-PCR and quantitative real-time RT-PCR expression
analyses [49,76-78]. The primer pairs ON15265/ON15266
and ON15265/ON15267 were used to amplify the first and
the second splice variant separately. Both primer pairs did
not produce any non-specific fragments during RT-PCR
reactions and the fragment sizes were between 100
and 200 bp which is the optimal fragment size for quantita-
tive real-time RT-PCR [79]. The expression levels were
Figure 4 Gene structures and alternative splicing of ten sample genes. Two splice variants (V1 and V2) are shown for each gene. Grey boxes are
exons and the carets represent introns. Arrow heads indicate the position of primers used for amplification of the respective alternative splicing variant (V1
or V2); primers used for amplification of both splice variants in one reaction tube are shown in the depiction of V1 (Additional file 1: Table S3). Dashed
lines indicate that a primer spans an exon-exon junction; the exact position of the exon-exon boundary within such a primer is given in Additional file 1:
Table S3. Genes that undergo exon skipping are clpr2 (A), efg8 (B), hyd2 (C), lsg2 (D), mgmt (E), nrnp1 (F) and selEFf (G). cyn23 (H) has mutually exclusive
exons, oee1 (I) shows intron retention and ppi1 (J) uses alternative 5′ splice sites. In the second splice variant (V2) of ppi1, 21 bp at the 5′ side of the intron
are retained (black area).
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Figure 5 RT-PCR amplification of characteristic fragments of the different splice variants. The investigated sample genes with alternative
splicing were clpr2 (A), efg8 (B), hyd2 (C), lsg2 (D), mgmt (E), nrnp1 (F), selEFf (G), cyn23 (H), oee1 (I) and ppi1 (J). Primers were designed to
amplify a characteristic fragment of each alternative splicing variant specifically (Figure 4 and Additional file 1: Table S3). The amplicons of the first
(V1) and second (V2) alternative splicing variants have been cloned and sequenced. The expected lengths of fragments are given in Additional
file 1: Table S3. DNA fragments that are consistent with the predictions are marked by arrowheads.
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[78] and the results are shown in Figure 7A. The expression
of the first splice variant of clpr2 is ~1.6 fold less than actin
and ~35.8 fold higher than the expression of the second
splice variant (Figure 7A).Figure 6 Single-tube RT-PCR amplification of different splice
variants. The investigated sample genes with alternative splicing
were efg8, mgmt, lsg2, selEFf, nrnp1 and clpr2. Both splice variants of
each gene were amplified in one and the same reaction using only
a single pair of primers (Additional file 1: Table S3). The amplicons
have been cloned and sequenced. The expected lengths of
fragments are given in Additional file 1: Table S3. DNA fragments
that are consistent with the predictions are marked by arrowheads.The second exon skipping candidate was efg8 (Figure 4B,
Additional file 1: Table S2). This gene codes for the mito-
chondrial elongation factor EF-TU and it is localized at
the mating type locus of Volvox [50]. EF-TU elongation
factors belong to the large family of GTP-binding elong-
ation factors [80]. The first splice variant of efg8 encodes
a polypeptide of 453 amino acid residues, including
three elongation factor domains, i.e. EF-TU, EFTU-II and
EFTU-III (Additional file 1: Figures S2A-B). All three do-
mains are essential for the elongation phase in protein
synthesis [81]. The first domain, EF-TU, is the catalytic
domain, which is responsible for the binding to the guan-
ine nucleotide [82]. The non-catalytic domains II and III
show a beta-barrel structure with six anti-parallel strands,
which appear to be tightly associated to the catalytic do-
main [82,83]. Interestingly, six exons are excluded in the
second splice variant, which reduces the length of the
mRNA by 510 nucleotides and the encoded polypeptide
chain by 170 amino acid residues (Figure 4B, Additional
file 1: Figure S2A). In the second variant, 139 amino acid
residues of the catalytic EF-TU domain are lacking, which
will in all likelihood affect the binding properties of the
domain. Moreover, GTP-binding proteins usually have
two conserved sequences with the consensus sequences
Asn-Lys-x-Asp (residues 192 to 195 in the first variant)
and Ser-Ala-Leu/Lys (residues 230 to 233 in the first vari-
ant), which are important for the binding to a guanine
nucleotid [84]; both motives are lacking in the second
variant (Additional file 1: Figure S2A). The first part of the
EFTU-II domain also is absent in the second variant,
which should cause altered binding properties and, thus,
Figure 7 Quantitative expression analysis of alternative splicing variants by real-time RT-PCR. The investigated sample genes with
alternative splicing were clpr2 (A), cyn23 (B), hyd2 (C), oee1 (D), lsg2 (E) and ppi1 (F). Primers were designed to amplify a characteristic fragment
of each alternative splicing variant specifically (Figure 4 and Additional file 1: Table S3). On the left side of each panel, the expression levels of
both alternative splicing variants are shown in relation to the actin gene (the expression level of actin was set as 100%). On the right side of each
panel, the expression levels of both alternative splicing variants are compared against each other (the expression level of V1 was set as 100%).
Kianianmomeni et al. BMC Genomics 2014, 15:1117 Page 9 of 21
http://www.biomedcentral.com/1471-2164/15/1117
Kianianmomeni et al. BMC Genomics 2014, 15:1117 Page 10 of 21
http://www.biomedcentral.com/1471-2164/15/1117affect its activity in RNA translation [85,86]. For amplifica-
tion of the first splice variant of efg8 by RT-PCR, the primer
ON15273 resides on exon 5 and primer ON15274 is
located on exon 6; both exons are lacking in the mRNA of
the second splice variant. For verification of the second
splice variant, one primer, ON15271, only binds to the
exon-exon junction of exons 4 and 11, which emerges only
after removal of a large fragment (10772 bp) between exon
4 and exon 11 by splicing; the second primer was
ON15272 on exon 12. A 151-bp cDNA fragment was
predicted for variant 1 and a 176-bp fragment for variant
2; the RT-PCR yielded fragments of the expected sizes
(Figure 5B, Additional file 1: Table S3). It was also possible
to amplify both variants in one and the same reaction using
only a single pair of primers (ON15365 and ON15366,
Figure 4B and in Additional file 1: Table S3). Fragments of
664 bp (variant 1) and 154 bp (variant 2) were expected
and actually obtained in the RT-PCR (Figure 6 and
Additional file 1: Table S3). The relative expression levels of
both splice variants of efg8 could not be determined by
quantitative real-time RT-PCR because non-specific side
products defeated the analysis repeatedly (the same was
true for mgmt, nrnp1 and selEFf).
The third sample gene was hyd2. This gene codes for an
iron hydrogenase, which catalyzes the reversible conversion
of molecular hydrogen to protons and electrons [87,88]
(Figure 4C, Additional file 1: Table S2). The first splice
variant of hyd2 encodes a polypeptide with a large Fe-only
hydrogenase domain, which is 352 amino acid residues long
(residues 82 to 434). In the second splice variant, 169
amino acid residues are lacking at the N-terminal end of
the polypeptide (Figure 4C, Additional file 1: Figure S3A),
including 88 amino acid residues of the Fe-only hydrogen-
ase domain [89,90]. The X-ray crystal structure of the Fe-
only hydrogenase from Clostridium pasteurianum could
show that the amino acid residues 90 to 97 and 130 to 135
are essential to form β sheets around the active site [91]
(Additional file 1: Figure S3A). Lack of this part in the
second splice variant should change the protein structure
and, as a consequence, the enzyme characteristics. In con-
trast, the actual active site is present in both variants of the
Fe-only hydrogenase [90] (Additional file 1: Figure S3A).
There are three conserved protein sequence motifs in the
active site of variant 1, motif 1 (PMFTSCCPxW, residues
169 to 178), motif 2 (MPCxxKxxExxR, residues 228 to 239)
and motif 3 (FxExMACxGxCV, residues 415 to 426), and
variant 2 contains exactly the same motifs except for the
very first amino acid residue of motif 1. For amplification of
the first splice variant of hyd2 by RT-PCR, one primer,
ON15276, resides on exon 3, which is lacking in the mRNA
of the second splice variant; the second primer was
ON15276 on exon 1 (Figure 4C and Additional file 1: Table
S3). For verification of the second splice variant, one
primer, ON15277, only binds to the exon-exon junction ofexons 2 and 5, which emerges only after removal of a
818 bp fragment between exon 2 and exon 5 by splicing;
the second primer was ON15275 on exon 1 (Figure 4C and
Additional file 1: Table S3). A 128-bp cDNA fragment was
predicted for variant 1 and a 102-bp fragment for variant 2;
the RT-PCR yielded fragments of the expected sizes
(Figure 5C, Additional file 1: Table S3); the band of variant
2 showed a lower intensity than the band of variant 1. It
was not possible to amplify both variants of hyd2 in one
and the same reaction, instead only one of both variants
was amplified (the same was true for cyn23, oee1 and ppi1).
However, the relative expression levels of both splice
variants could be determined by quantitative real-time RT-
PCR. The expression of the first splice variant of hyd2 is
only ~1.5 fold higher than the expression of the second
splice variant (Figure 7C). Compared to actin, both splice
variants are expressed at a very low level, i.e. hyd2 variants
1 and 2 account for only 2.4% and 1.7%, respectively, of the
actin expression level (Figure 7C).
The fourth exon skipping candidate was lsg2. This Volvox
gene codes for a matrix metalloproteinase; lsg2 was shown
to be expressed with an above-average rate during the late
developmental stages in somatic cells [92] (Additional
file 1: Table S2). Lsg2 (variant 1) shows 31% identity to the
gamete lytic enzyme (GLE) of Chlamydomonas in an over-
lap of 537 amino acid residues. GLE of Chlamydomonas is
a proteinase, which degrades cell walls of gametes during
mating [93]. For enzymatic degradation, it contains a large
peptidase M11 domain (amino acid residues 146 to 458 in
variant 1, Additional file 1: Figure S4A) The M11 domain is
conserved among several metalloproteinases including
VMPs [94,95]. The typical HExxHxxGxxH motif, which
contains four histidine residues for zinc binding in the
active site of the enzyme [96] can be found in variant 1 of
Lsg2 (amino acid residues 301 to 312, Additional file 1:
Figure S4A). Another motif, which is believed to be respon-
sible for the binding to calcium, is also conserved in variant
1 of Lsg2 (amino acid residues 500 to 512, Additional file 1:
Figure S4A). In contrast, 103 amino acid residues of the
peptidase M11 domain are lacking in the polypeptide
encoded by the second splice variant, because exon nine
(309 bp) is excluded by exon skipping (Figure 4D,
Additional file 1: Figure S4A). For amplification of the first
splice variant of lsg2 by RT-PCR, one primer, ON15295,
resides on exon 9, which is lacking in the mRNA of the
second splice variant; the second primer was ON15294 on
exon 8 (Figure 4D and Additional file 1: Table S3). For
verification of the second splice variant, one primer,
ON15296, only binds to the exon-exon junction of exons 8
and 10, which emerges only after removal of a 2285 bp
fragment between exon 8 and exon 10 by splicing; the
second primer was ON15294 on exon 8 (Figure 4D and
Additional file 1: Table S3). A 137-bp cDNA fragment was
predicted for variant 1 and a 131-bp fragment for variant 2;
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(Figure 5D, Additional file 1: Table S3). It was also possible
to amplify both variants in one and the same reaction using
only a single pair of primers (ON15294 and ON15368,
Figure 4D and Additional file 1: Table S3). Fragments of
482 bp (variant 1) and 173 bp (variant 2) were expected
and actually obtained in the RT-PCR (Figure 6 and
Additional file 1: Table S3); it should be mentioned that in
addition to the correct fragments, some non-specific side
products were amplified (Figure 6). Quantitative real-time
RT-PCR showed that both splice variants are expressed at a
very low level in comparison to actin. However, the expres-
sion of the first splice variant of lsg2 is ~10 fold higher than
the expression of the second splice variant (Figure 7E).
The fifth sample gene was mgmt. This gene codes for a
putative 6-O-methylguanine DNA methyltransferase
(Additional file 1: Table S2). The O-6-methylguanine-DNA
methyltransferase is essential for viability because it
reverses DNA alkylation damage by removing the offending
alkyl group [97-99]. The first splice variant of mgmt
encodes a polypeptide with 153 amino acid residues in
length (Additional file 1: Table S2, Additional file 1: Figure
S5A) and contains a DNA binding domain, which is 89
amino acid residues long [100] (Additional file 1: Figure
S5A,B). As a result of the exon skipping event, 29 residues
are lacking in the DNA binding domain of the second
variant (Figure 4E, Additional file 1: Figure S5A). Some of
these 29 amino acid residues were previously shown to be
involved in DNA binding [101]. For example, the tyrosine
residue at position 44 of variant 1 (Y44, Additional file 1:
Figure S5A) has been shown to be a key residue involved in
recognition of the O6-alkylguanine lesion through a hydro-
gen bond with the N3 atom of the modified base [101,102].
Furthermore, the arginine residue at position 56 of variant
1 (R56, Additional file 1: Figure S5A) is necessary for the
repair of base damage in duplex DNA [100]. The absence
of these two amino acid residues most probably affects the
binding characteristics of the second protein variant. For
amplification of the first splice variant of mgmt by RT-PCR,
one primer, ON15279, resides on exon 2, which is lacking
in the mRNA of the second splice variant; the second
primer was ON15278 on exon 1 (Figure 4E and Additional
file 1: Table S3). For verification of the second splice vari-
ant, one primer, ON15280, only binds to the exon-exon
junction of exons 1 and 3, which emerges only after
removal of a 276 bp fragment between exon 1 and exon 3
by splicing; the second primer was ON15278 on exon 1
(Figure 4E and Additional file 1: Table S3). A 173-bp cDNA
fragment was predicted for variant 1 and a 165-bp fragment
for variant 2; the RT-PCR yielded fragments of the expected
sizes (Figure 5E, Additional file 1: Table S3); in the PCR of
variant 1 also two larger, non-specific side products were
amplified, as verified by cloning and sequencing. It was also
possible to amplify both variants in one and the samereaction using only a single pair of primers (ON15278 and
ON15367, Figure 4E and Additional file 1: Table S3).
Fragments of 310 bp (variant 1) and 223 bp (variant 2) were
expected and actually obtained in the RT-PCR (Figure 6
and Additional file 1: Table S3); it should be mentioned that
in addition to the correct fragments, a larger, non-specific
side product was amplified (Figure 6).
The sixth exon skipping candidate was nrnp1. This
Volvox gene codes for a polypeptide with two RNA recog-
nition motif (RRM) domains, also known as RNA binding
domains (RBDs). The RRM domain is by far the most
abundant type of eukaryotic RNA-binding motif. This
domain is involved in different cellular processes like
mRNA and rRNA processing, RNA export and RNA stabil-
ity [103-105]. The first splice variant of nrnp1 encodes a
polypeptide with 344 amino acid residues; the RRMs are
localized at amino acid residues 76 to 132 and 150 to 219
(Additional file 1: Table S2, Additional file 1: Figure S6A).
The protein product of the second splice variant is 179
amino acid residues shorter than the first variant (Figure 4F
and Additional file 1: Figure S6). In the second variant,
the first RRM domain is lacking and the second RRM
domain is truncated, i.e., 29 amino acid residues are lacking
(Additional file 1: Figure S6A). The crystal structure ana-
lysis of the RRM domain previously showed that the first
part of the domain is important for correct folding [106].
The complete elimination of the first RRM and the trunca-
tion of the second RRM domain most probably change the
RNA binding capacity significantly in the second variant.
For amplification of the first splice variant of nrnp1 by RT-
PCR, one primer, ON15287, resides on exon 2, which is
lacking in the mRNA of the second splice variant; the
second primer was ON15286 on exon 1 (Figure 4F and
Additional file 1: Table S3). For verification of the second
splice variant, one primer, ON15288, only binds to the
exon-exon junction of exons 1 and 3, which emerges only
after removal of a 542 bp fragment between exon 1 and
exon 3 by splicing; the second primer was ON15286 on
exon 1 (Figure 4F and Additional file 1: Table S3). A
116-bp cDNA fragment was predicted for variant 1 and a
107-bp fragment for variant 2; the RT-PCR yielded
fragments of the expected sizes (Figure 5F, Additional file 1:
Table S3). It was also possible to amplify both variants in
one and the same reaction using only a single pair of
primers (ON15286 and ON15370, Figure 4F and Additional
file 1: Table S3). Fragments of 342 bp (variant 1) and 152 bp
(variant 2) were expected and actually obtained in the RT-
PCR (Figure 6 and Additional file 1: Table S3); it should be
mentioned that in addition to the correct fragments, a larger,
non-specific side product was amplified (Figure 6).
The seventh and last exon skipping candidate was
selEFf, which is localized at the mating type locus of
Volvox [50] (Additional file 1: Table S2). This gene codes
for a putative selenocysteine-specific elongation factor
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incorporation of selenocysteine into proteins; selEFfs
probably replace EF-Tu for the insertion of selenocysteine
directed by the UGA codon [107]. In the first splice vari-
ant of selEFf, a very short exon (exon 4, 56 bp) is flanked
by two very large introns, 7,996 bp and 8,313 bp in length
(Figure 4G). This exon is excluded from the second splice
variant by exon skipping and thus, an intron of 16,365 bp
is spliced out. This intron seems to be the largest intron
reported so far in Volvox. The alternative splicing event in
the second variant also introduces a premature stop codon
into the open reading frame (Additional file 1: Figure
S7A). Unfortunately, no information about the structure
of selEFf proteins is available, but the elimination of 142
amino acid residues in the second splice variant means
that the length of the polypeptide is almost halved relative
to the first variant and this significant cut-off probably af-
fects the structure and characteristics of this translation
factor. For amplification of the first splice variant of selEFf
by RT-PCR, one primer, ON15290, resides on exon 4,
which is lacking in the mRNA of the second splice variant;
the second primer was ON15289 on exon 3 (Figure 4G
and Additional file 1: Table S3). For verification of the sec-
ond splice variant, one primer, ON15291, only binds to
the exon-exon junction of exons 3 and 5, which emerges
only after removal of a 16365 bp fragment between exon 3
and exon 5 by splicing; the second primer was ON15289
on exon 3 (Figure 4G and Additional file 1: Table S3). A
196-bp cDNA fragment was predicted for variant 1 and a
166-bp fragment for variant 2; the RT-PCR yielded frag-
ments of the expected sizes (Figure 5G, Additional file 1:
Table S3); in addition to the correct fragments, a larger,
non-specific side product was amplified in the RT-PCR for
the second variant. It was also possible to amplify both
variants in one and the same reaction using only a single
pair of primers (ON15289 and ON15369, Figure 4G and
Additional file 1: Table S3). Fragments of 357 bp (variant
1) and 301 bp (variant 2) were expected and actually
obtained in the RT-PCR (Figure 6 and Additional file 1:
Table S3); in addition to the correct fragments, some non-
specific side products were amplified (Figure 6).
Verification of mutually exclusive exons
The sample gene for mutually exclusive exons was cyn23,
which encodes a cyclophilin-related protein (Additional
file 1: Table S2). Cyclophilins are ubiquitous proteins
that belong to the family of peptidyl-prolyl cis/trans isom-
erases (PPIases) [108], also known as immunophilins.
These immunophilins are proposed to function in protein
folding, protein degradation, stress response, signal trans-
duction and pre-mRNA splicing [109-113]. The cyn23 gene
contains two alternate mutually exclusive exons, exons 4
and 5. Because both exons are 106 nucleotides in length
(Figure 4H, Additional file 1: Figure S11), the number ofamino acid residues of the two protein isoforms is identical.
However, the two isoforms differ from each other at 13
amino acid positions: A125G, G127Y, G128D, N129D,
K130P, G132S, A133G, R134A, V139I, E150Q, A152T,
I153A and G155A (Additional file 1: Figure S8A). Some of
these residues, like alanine at position 125, have been re-
ported to be part of the cyclosporin-binding site [114,115].
Moreover, exchange of amino acids between positions 116
and 155 by site-directed mutagenesis was shown to affect
the binding properties of cyclophilins [116,117]. Therefore,
the differences in amino acid sequence between the two
isoforms might produce isoforms with different binding
properties. For amplification of the first splice variant of
cyn23 by RT-PCR, one primer, ON15269, resides on exon 4
and the second primer is ON15268 on exon 3 (Figure 4H
and Additional file 1: Table S3). For verification of the sec-
ond splice variant, one primer, ON15270, resides on exon 5
and the second primer again was ON15268 on exon 3. A
145-bp cDNA fragment was predicted for variant 1 and a
146-bp fragment for variant 2; the RT-PCR yielded frag-
ments of the expected sizes (Figure 5H, Additional file 1:
Table S3). Due to the almost identical fragment sizes and
the resulting identical migration distances in the gel, both
variants were not amplified in one and the same reaction.
Quantitative real-time RT-PCR showed that both splice
variants are expressed at a very low level in comparison to
actin. However, the expression of the first splice variant of
cyn23 is ~2.8 fold higher than the expression of the second
splice variant (Figure 7B).
Verification of intron retention
The candidate gene for verification of intron retention was
oee1, which codes for a subunit of the oxygen evolving
complex of photosystem II (Additional file 1: Table S2).
Previously, it was demonstrated that oee1 is subject to
germline-specific expression in Volvox [118,119]. The first
splice variant of oee1 encodes a polypeptide of 297 amino
acid residues (Additional file 1: Figure S9A, Additional file
1: Table S2), which shows 87% identity to OEE1 of Chlamy-
domonas in an overlap of 294 amino acid residues [120]. It
includes a large manganese-stabilizing protein (MSP)
domain (Additional file 1: Figure S9A, B), which is required
for photosystem II assembly, stability and photoautotrophy
[121]. In the second splice variant of oee1, the first intron
(69 bp in length) is retained by alternative intron retention
(Figure 4I), which potentially leads to an N-terminally
truncated protein isoform with a shortened MPS domain
(Additional file 1: Figure S9A,B).
For verification of the first splice variant of oee1 by RT-
PCR, one primer, ON15285, only binds to the exon-exon
junction of exons 1 and 2, which emerges only after
removal of intron 1 (69 bp) by splicing; the second primer
was ON15281 on exon 1 (Figure 4I and Additional file 1:
Table S3). For amplification of the second splice variant,
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sequence (intron 1 of variant 1), which therefore is lacking
in the mRNA of the first splice variant; the second primer
was ON15281 on exon 1 (Figure 4I and Additional file 1:
Table S3). A 111-bp cDNA fragment was predicted for
variant 1 and a 158-bp fragment for variant 2; the RT-PCR
yielded fragments of the expected sizes (Figure 5I, Add-
itional file 1: Table S3). Quantitative real-time RT-PCR
showed that the expression of the first splice variant of oee1
is ~17 fold higher than actin; whereas the expression of the
second variant is ~11 fold less than actin (Figure 7D).
The bioinformatic analysis of EST sequences revealed a
third splice variant of ooe1. For verification of this variant
by RT-PCR, one primer, ON15283, only binds to the exon-
exon junction of exons 1 and 3, which emerges only after
removal of a 356 bp fragment between exon 1 and exon 3
by splicing; the second primer was ON15281 on exon 1
(Figure 4I and Additional file 1: Table S3). A 112-bp cDNA
fragment was predicted for variant 3. However, we were
not able to confirm this variant by RT-PCR (Figure 5I,
middle lane).
Verification of alternative 5′ splice sites
The sample gene for alternative 5′ splice sites was ppi1,
which codes for a protein with an Ypi1 domain (Additional
file 1: Table S2). The Ypi1 domain is a Saccharomyces
cerevisiae type 1 protein phosphatase inhibitor [122]. The
gene ppi1 of Volvox is a quite small gene with a single
intron, which is 100 bp in length. The first splice variant of
ppi1 encodes a 100-amino-acid polypeptide, which shows
82% identity to the FAP255 protein of Chlamydomonas.
FAP255 is a flagellar associated protein found in the
flagellar proteome [59,123] (Additional file 1: Table S2,
Additional file 1: Figure S10A). In the second splice variant,
21 bp at the 5′ side of the intron are retained and thereby a
premature stop codon is introduced (Figure 4J). As a
consequence, a shortened protein isoform with a truncated
Ypi1 domain is produced (Additional file 1: Figure S10B).
For verification of the first splice variant of ppi1 by RT-
PCR, one primer, ON15302, only binds to the exon-exon
junction of exons 1 and 2, which emerges only after
complete removal of the 100 bp of intron 1 by splicing; the
second primer is ON15300 on exon 1 (Figure 4J and
Additional file 1: Table S3). For amplification of the second
splice variant, one primer, ON15301, resides on the
retained 21 bp of intron 1, which therefore is lacking in the
mRNA of the first splice variant; the second primer was
ON15300 on exon 1 (Figure 4J and Additional file 1: Table
S3). A 140-bp cDNA fragment was predicted for variant 1
and a 141-bp fragment for variant 2; the RT-PCR yielded
fragments of the expected sizes (Figure 5J, Additional file 1:
Table S3); the band of variant 2 showed a lower intensity
than the band of variant 1. Quantitative real-time RT-PCR
showed that the expression of the first splice variant of ppi1is ~70% higher than the expression of actin and even
~1000% higher than the expression of variant 2.
Discussion
A comparative view on alternative splicing in Volvox
This work provides a bioinformatic analysis of 132,038
ESTs in relation to alternative splicing events in the multi-
cellular green alga Volvox. The results show that 66.7% of
the alternative splice events are within the coding region
(Figure 3A) and thus have an effect on the protein sequence
and, as a consequence, frequently also on protein structure
and function. The remaining 33.3% of all alternative splice
events in Volvox were within the 5′ and 3′ UTRs
(Figure 3A), which is higher than reported data (21-28.5%)
from Arabidopsis (Figure 3C), mouse and human
[5,124-127] and this study). Thus, UTRs in the alga Volvox
are more frequently target of alternative splicing than UTRs
in the land plant Arabidopsis (Figures 3A and 3C). Alter-
native splicing of UTRs can play a key role both in regula-
tion and in the production of mRNA diversity [11,128].
Moreover, changes in mRNA secondary structure can affect
RNA processing, mRNA stability and translation of the
messenger [129-131]. In addition, it possibly creates pheno-
typic variability [132]. In multicellular organisms, regulation
of mRNA stability plays a crucial role in development,
growth and differentiation [133]. That data indicate that
there might be more variability and diversity through
alternative splicing in Volvox UTRs than in Arabidopsis
UTRs (Table 1, Figures 3A and 3C).
The distribution scheme of the different types of alterna-
tive splicing in Volvox shows that intron retention is the
predominant type, while exon skipping is only a smaller
part (46.5% versus 9.5%; Table 1, Figure 2A). Interestingly,
the situation in human is just opposite to the situation in
Volvox: there are only 1% intron retention events and
35.6% exon skipping events (Table 1). These highly differing
distributions could result from different genome features.
For example, the introns in human are much longer than
in Volvox, or to be more exact, the median sizes of introns
are 1,504 bp versus 358 bp [58,135]. The size of introns is
crucial factor in the mechanism of intron retention, i.e.,
short introns were shown to be much more frequently
retained than longer introns [136-138]. On the contrary, an
increase in intron length correlates positively with promo-
tion of the exon skipping mechanism [65,139,140]. There-
fore, intron length is the determining factor for the switch
from the intron definition mechanism, in which the 5′ and
3′ splice sites are initially recognized and paired across the
intron, to the exon definition mechanism, in which splice
sites are paired first across the exons, with spliceosome
assembly proceeding through subsequent pairing of exon
units [141]. Thus, a plethora of short introns is Volvox is
probably recognized and spliced out through the intron
definition mechanism, while in human the exon definition
Table 1 The occurrence of alternative splicing events in Volvox in comparison to Chlamydomonas, Arabidopsis and
human









5′ splice site [%]
Alternative
3′splice site [%]
Volvox carteri1* 132,038 2.9 9.5 46.5 17.9 21.9
Chlamydomonas reinhardtii2** 252,484 3 11.9 50.0 11.6 25.8
Arabidopsis thaliana3 541.594 20 3 41 18 38
Human4*** 435 million cDNA reads 90 40 3 8 18
1 this study, 2 [53], 3 [26],4 [16,134].
*4.2% show other alternative splicing events.
**0.7% show both alternative 5′ splice site and alternative 3′ splice sites.
*** 32.7 % show other alternative splicing events such as exclusive exon, alternative first exon, alternative last exon and tandem 3′ UTR.
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flanked by long introns [140,141]. It should be noted that
the introns of Chlamydomonas are even somewhat (~25%)
shorter than those in Volvox, i.e., the average lengths are
491 bp and 373 bp, respectively (Additional file 1: Table
S1), but the calculated intron retention rate is about the
same in both organisms (Figure 2, Table 1). However, the
intron lengths of both species can be considered as short
and therefore the intron definition mechanism seems to
apply for both species to the same extend.
Our analysis of ESTs in Volvox revealed that 2.9% of all
Volvox genes undergo alternative splicing, which is similar
to the reported 3% for Chlamydomonas [53]. The absolute
numbers of alternative splicing events were 580 for Volvox
and 493 for Chlamydomonas (Figure 2). However, it should
be noted that the absolute numbers and percentages have
been calculated based on different total EST numbers, i.e.,
the number of analyzed ESTs in Chlamydomonas (252,484)
was almost twice that of Volvox (132,038) (Table 1) even if
the total number of protein-coding loci is about the same
in Volvox (14,520) and Chlamydomonas (14,516) [58].
Because the total number of ESTs is a critical value for
detection of alternative splicing events, probably more
alternative splicing events remained undetected in Volvox
than in Chlamydomonas. These results and considerations
indicate that actually the rate of alternatively spliced genes
is higher in Volvox than in Chlamydomonas and, thus, also
the variability and diversity through alternative splicing
appears to be higher in Volvox. However, the data presented
here are not corrected for the amount of transcript
evidence available.
The number of ESTs analyzed in Volvox (132,038) is
similar to the number of ESTs analyzed in Arabidopsis
(176,915) in a study by Zhu et al. in 2003 [22], which came
to a value of 1.5% alternatively spliced genes for Arabidopsis
(Additional file 1: Figure S12). As mentioned above, nine
years later, after sequencing countless more ESTs, the rate
was calculated to be 61% [18,19]. Therefore, in actual fact,
alternative splicing in the alga Volvox might be just as com-
mon as in higher eukaryotes like Arabidopsis, Drosophila
or even human [13,17] [14-16,19].Some striking alternative splicing events in Volvox
During our genome-wide analysis, we found some genes
with remarkable alternative splicing variants regarding
the size or number of excluded introns and exons.
One of these genes is efg8, which is subject to exon
skipping (Figure 4B). The first splicing variant of efg8
contains 15 exons. In the second splicing variant even six
consecutive exons (5 to 10) are skipped at once. These
exons are quite short, i.e., between 44 and 121 bp in size,
and also the sequences between the exons are short
(between 162 and 718 bp). However, two extremely long
introns flank the skipped sequence: The introns 4 (between
exon 4 and 5) and 10 (between exon 10 and 11) are 3,958
and 4,407 bp in length, respectively (Figure 4B). Thus, in
the second splicing variant an intron of 10,772 bp is spliced
out, which contains exons 5-10 and introns 4-11. This
spliced fragment of the second variant is one of the longest
introns identified in Volvox so far (Figure 4B). In Arabidopsis
and maize, the longest reported introns are about 3 and
7 kb in length, respectively [142-144]. The longest introns
among all plants have been identified in tobacco and rice,
which are about 17 and 28 kb in length, respectively
[145,146]. In general, especially long introns can contain
regulatory elements to control gene expression under
certain conditions (development, cell-type specificity, envir-
onmental influences) [147,148].
The selEFf gene is also subject to exon skipping. The
first splicing variant of selEFf contains 7 exons. In the
second splicing variant a single small exon (exon 4), only
56 bp in length, is skipped. This exon is flanked by two
extremely long introns, which are 7,996 and 8,313 bp in
length, respectively (Figure 4G). Thus, in the second
splicing variant an intron of 16,365 bp is spliced out
(Figure 4G), which contains exon 4, intron 3 and intron 4.
This spliced ~16 kb fragment of the second variant is one
of the longest introns identified in the plant lineage so far;
it is longer than any intron in Arabidopsis or maize.
Alternative splicing and organismal complexity
Alternative splicing is a major mechanism for generating
proteome diversity, which probably was co-opted in
Figure 8 Alternative splicing status of orthologous gene pairs
of Volvox and its closely related, unicellular relative
Chlamydomonas. Comparison of the ten investigated sample genes
of Volvox with their orthologs in Chlamydomonas regarding
alternative splicing events. A green background shows genes with
alternative splice events, a red background indicates that genes do
not exhibit alternative splicing. Numbers indicate the EST coverage
of given genes in Volvox (V.c.) or Chlamydomonas (C.r.).
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http://www.biomedcentral.com/1471-2164/15/1117evolution of multicellular complexity [149]; it plays a crit-
ical role in differentiation and development of multicellu-
lar eukaryotes [128,150]. Because Volvox only has about
the same number of protein-coding genes compared to its
unicellular relative Chlamydomonas, alternative splicing
could have contributed to an increase in proteome diver-
sity when a unicellular Chlamydomonas-like ancestor
evolved to the multicellular Volvox alga with its differenti-
ated cells. In more concrete terms, the transition to multi-
cellularity in volvocine algae required a proteome with an
increased capacity to address new traits and tasks like
multicellularity, cell differentiation, multicellular motility
and phototaxis as well as egg and sperm formation. Alter-
native splicing seems to be particularly important for the
generation of new or modified regulatory proteins, which
are indispensable in the evolution of multicellular com-
plexity [125]. Especially transcription factors and signal
transducers that act as key regulators in complex, multi-
cellular systems seem to be subject to extensive alternative
splicing [124,125,151].
In our analysis we found some evidence that alterna-
tive splicing actually affects key regulators. For example,
the retinoblastoma gene rbr1/mat3, which codes for a
key cell cycle and cell size regulator [49,152], is only
subject to alternative splicing in the multicellular alga
Volvox; no such event has been reported its close unicel-
lular relative Chlamydomonas [49,50,152]. This gene also
shows gender-specific splicing in Volvox and it is be-
lieved to be involved by the evolution of oogamy
[50,153]. Also worth mentioning is the general distribu-
tion of alternatively spliced genes in Volvox in relation
to its unicellular relative Chlamydomonas. For it, we took
one-hundred alternatively spliced genes from Volvox and
compared them with the corresponding orthologs in
Chlamydomonas. Ten of these one-hundred genes were
those that were selected for experimental verification and
another ninety alternatively spliced genes were randomly
selected. The results are shown in Figure 8 and Additional
file 1: Table S4. The comparison demonstrates that the
largest fraction of alternatively spliced genes in Volvox
(70% of the analyzed genes) does not exhibit alternative
splicing in the unicellular alga Chlamydomonas. The lack
of alternative splicing events for those genes in Chlamydo-
monas is not due to poor EST support, because the total
number of ESTs is lower for the Volvox genes than for
their orthologs in Chlamydomonas (Figure 8 and Add-
itional file 1: Table S4). This observation supports the idea
that alternative splicing events increased during evolution
from the unicellular ancestor to the multicellular alga
Volvox in order to expand the transcript diversity and, as a
consequence, the proteomic diversity. Recently, the group
of Urrutia also demonstrated a strong association between
alternative splicing and organism complexity [1]. In
addition to alternative splicing, gene duplication followedby divergence also increases proteome diversity [65].
During evolution of multicellular volvocine algae, the
number of members in several protein families increased
significantly through gene duplication. The families with
the most extensive expansions are the VMPs, the phero-
phorins and the cyclin Ds, which are involved in the
(partly gender-specific) biosynthesis of the extracellular
matrix and in the regulation of cell division program
during development [58].
However, in contrast to the extent of gene duplications,
which remains invariant after sequencing of the genome,
it can be expected that the percentage of alternatively
spliced genes will increase strongly in Volvox when more
and more EST data and full-length cDNA sequences be-
come available, just as it happened earlier in Arabidopsis
[18,19,22-24,154]. In all probability, deep sequencing of
the Volvox transcriptome during asexual and sexual devel-
opment, during embryonic cleavage divisions and cellular
differentiation and under various environmental condi-
tions (e.g., heat and light stress or nutrient deprivation)
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becoming increasingly clear that alternative splicing is not
an exception, but relatively widespread in Volvox and
other eukaryotes. This degree raises quite difficult ques-
tions: Do all splice isoforms have functional significance?
How big is the noise in the splicing process? At which
extent do truncated and misfolded proteins play a role in
cellular regulation? Which amount of inadvertently
produced isoforms can be tolerated by a cell? However,
frequently alternative splicing seems to be part of molecu-
lar mechanisms that allow (some) cells of an organism to
decrease the concentration of certain (functional) proteins
without changing the transcription rate of the correspond-
ing genes. Instead, shortened or modified non-functional
mRNA variants are generated by alternative splicing. In
this way, specific cellular and physiological processes can
be attenuated, altered or even intensified at the post-
transcriptional level.
In human, splicing error rates of 1 to 10 percent have
been calculated [155,156], but it remains difficult to
distinguish between functional and non-functional isoforms
because also truncated proteins might have a function. In
several studies, criteria like abundance, conservation of
splicing events across species, tissue specificity and
developmental stage specificity have been used to assess
functionality [155,157]. Different models proceed on the
assumption that the splicing machinery makes mistakes at
a constant error rate, is dependent on the number of
introns or is determined by the number of introns and
transcript abundance [155,157].
However, the noise in the splicing process should not be
considered as a collateral damage of splicing. Noise in
splicing might have been an important factor in the
evolution of multicellularity in volvocine algae because it
creates a landscape of opportunities in which novel
biological activity can be explored at very little cost [155].Conclusions
Our results show that the approach for prediction of
alternative splicing events in Volvox was accurate and
reliable. Moreover, quantitative real-time RT-PCR ap-
pears to be useful for analyses of relationships between
the appearance of specific alternative splicing variants
and different kinds of physiological, metabolic and devel-
opmental processes as well as responses to environmen-
tal changes.Methods
Strain and culture conditions
Synchronous cultures of Volvox carteri f. nagariensis strain
EVE (wild-type female) [158] were grown in standard
Volvox medium [159] at 28°C in an 8 h dark/16 h light
(10,000 lux) cycle [160].Data sources
Genomic sequences of Volvox carteri f. nagariensis
(strain Eve) came from the Volvox carteri whole genome
shotgun sequencing project [58] (GenBank project
accession No. ACJH00000000). The genomic contigs of
Volvox are available both on the web pages of phyto-
zome (v10), the plant comparative genomics portal of
the Department of Energy’s Joint Genome Institute (JGI)
(http://www.phytozome.net/), and on the web pages of
the Volvox genome portal of JGI (http://genome.jgi-psf.
org/Volca1/Volca1.info.html). The sequences of 132,038
ESTs of Volvox carteri f. nagariensis were generated as
part of the Volvox genome project [58] and are available
at the GenBank EST database (http://www.ncbi.nlm.nih.
gov/dbEST/) and at the PlantGDB web resource (http://
www.plantgdb.org/). These ESTs were derived from the
female Volvox carteri f. nagariensis strains Eve and
Eve10 and the male strain 69-1b [58]. RNAs from Eve
and 69-1b were isolated 1.5, 10, 24, 48 hours after
sexual-induction and subsequently pooled. For Eve10,
extracted RNAs from 2-4 and 32-128 cell stages were
pooled. The sequences both of genomic contigs and
ESTs of Chlamydomonas came from the Chlamydomo-
nas whole genome shotgun sequencing project [59]. The
data are available both on the web pages of phytozome
(v10) and at the PlantGDB web resource. The genomic
and EST sequences of Arabidopsis came from the
Arabidopsis Genome Initiative (AGI) [31]. The data are
available both on the web pages of The Arabidopsis
Information Resource (TAIR) (http://www.arabidopsis.
org/) and at the PlantGDB web resource.
Genomic mapping of expressed sequence clusters
The ESTs of the three species Volvox, Chlamydomonas and
Arabidopsis were aligned to the corresponding genomic
contigs and genome sequences using BLAT, a BLAST-like
alignment tool [67]. To avoid double counting of paralogs,
we only used the best alignment. Sequences with less than
95% identity were removed from further analysis. The
resulting alignments were then clustered by genomic loca-
tion where each cluster is formed by the set of all ESTs
which overlap at a given location. The splice site consensus
sequences (GT/AG) were identified and sequences without
splice site consensus sequence were also removed. Subse-
quently, an alternative splicing graph of potential splice
variants was constructed. An intron in the splice graph was
constructed when there was EST evidence of a transcript
with appropriate splice sites.
Alternative splicing analysis
From the splice graphs, we identified alternatively spliced
isoforms. Isoforms with alternative transcription starts or
ends were not considered further in this paper. The iso-
forms were divided into four major groups of alternative
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5′ and alternative 3′ splicing. This was obtained by search-
ing for patterns of exons and introns that are consistent
with these events. In addition, there were instances of more
complex splice forms, which were not covered by the above
four simple alternative splicing events. To obtain high qual-
ity events, only events were included where the amount of
sequence evidence for both splice alternatives was within
ten times of each other. This was to exclude spurious
events due to a small number of ESTs.
Primer design
For verification of alternative splicing events, primers were
designed such that they have similar melting temperatures,
allowing both primers to anneal roughly at the same
temperature in RT-PCR and real-time RT-PCR experi-
ments. For each candidate gene, three pairs of primers were
chosen to amplify the first and the second splice variant
separately and also both splice variants together in one
reaction tube (Figure 4 and Additional file 1: Table S3). The
primers were designed using the primer analysis software
Oligo 6 (Molecular Biology Insights, Cascade, CO), DNA-
SIS (version 7.00; Hitachi Software Engineering, South San
Francisco, CA), or Primer Express (Applied Biosystems,
Foster City, CA).
Isolation of total RNA
Total RNA was extracted from 1 g frozen algae using 10 ml
of the phenol-based TRI Reagent (Sigma-Aldrich, St. Louis,
MO) and 3 ml trichloromethane. RNA was precipitated
from the aqueous phase by addition of isopropanol. All
preparation and handling steps of RNA took place under
RNase-free conditions. After final washing steps with etha-
nol, RNA was dissolved in RNase-free water and stored at
-70°C until used. RNA quantity and purity were determined
by measuring the 260/280 ratio using an UV/visible spectro-
photometer (Ultrospec 2100 pro, GE Healthcare, Uppsala,
Sweden). The quality of RNA was verified by electrophor-
esis of 0.5 μg RNA in a 1.3% agarose-formaldehyde gel.
RT-PCR
1 μg of extracted total RNA was treated with 5 units of
DNase I (Promega, Madison, WI) for 15 min at room
temperature and then DNase I was inactivated at 75°C for
10 min. 1 unit of M-MLV Reverse Transcriptase (Promega,
Madison, WI) and 1 μM of reverse primer were added for
synthesis of the first strand cDNA at 50°C for 60 min
(Figure 4, Additional file 1: Table S1). The synthesized
cDNA was used as a template for PCR according to standard
protocols [161].
Quantitative real-time RT-PCR
Quantitative real-time RT-PCR was performed on a DNA
Engine Opticon Continuous Fluorescence Detection System(MJ Research) using the SensiMix one-step kit (Quantace)
as described previously [78]. 300 ng total RNA was used
per 25 μl of reaction volume. The thermal cycling condi-
tions were identical for all quantification experiments, i.e.
after the first cDNA synthesis at 50°C for 30 min, DNA
polymerase was activated at 95°C for 10 min, followed by
40 cycles of denaturation at 95°C for 20 s, annealing at 55°
C for 30 s and extension at 72°C for 40 s. The expression
levels of splice variants were calculated in relation to a ref-
erence gene, the housekeeping gene actin [76,78,162], using
the 2-ΔΔCt method [163,164]. The Ct, ΔCt, and ΔΔCt values
were calculated as described previously [78]. All real-time
RT-PCR experiments were carried out in triplicate together
with controls lacking RT or template. The final products of
all real-time RT-PCR reactions were visualized using
agarose gel electrophoresis to ensure amplification of a
single product of the correct size.
Additional file
Additional file 1: Supplemental Material. Supplemental Figures S1 to
S12 Supplemental Tables S1 to S4 and Supplemental References.
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